Inve US ▾

Coupang (CPNG) earnings

Coupang, Inc.· Consumer Discretionary

Results to
Jun 2026
Latest analysed call
Jun 2026 (Q2 FY26)
Balance sheet to
Dec 2025

Company research is public. Sign in to keep your own companies, notes and cases.

Coupang earnings: last reported Tue, 4 Aug 2026, for the quarter ended Jun 2026.

Reported

The figures, each with its period

Each figure keeps its basis and period; nothing is filled in.

MetricValueChangeBasisPeriodNote
Revenue8,856 $ million+3.9% YoYQuarterly, as filedQuarter to Jun 2026Revenue from operations as filed.
Operating margin-6.3 %−8.0 pts YoYOperating profit / revenueQuarter to Jun 2026For the quarter; a change is in percentage points.
Net profit-570 $ million−1881.3% YoYQuarterly, as filedQuarter to Jun 2026Profit after tax as filed.

Source: Inve data from filed results (SEC filings) · to Jun 2026

Guidance

What management said, and what became of it

7 of 8 judged targets kept · 10 open · verdicts reflect calls analysed to Jun 2026.

Coupang, Inc. management guidance track record: 18 targets tracked across analysed earnings calls (7 achieved, 1 missed, 10 open).

TargetOriginal wordingSaidLatest callVerdict
Consolidated adjusted EBITDA margin y/y contraction, quarterly guideconsolidated adjusted EBITDA margin y/y contraction of approximately 300 to 400 basis pointsMar 2026Jun 2026:This represents a contraction of approximately 320 basis points year-over-year at the low end of the guidance range we provided.
Call transcript, Jun 2026 · no direct link
Achieved
Consolidated adjusted EBITDA margin expansion, annual (y/y)annual (year-over-year) consolidated adjusted EBITDA margin expansionDec 2025Jun 2026:Looking beyond Q3, we expect the improvements to become increasingly more evident with product commerce adjusted EBITDA margins by mid-2027, returning to margin levels approximating those we generated prior to the data incident.
Call transcript, Jun 2026 · no direct link
At Risk
Consolidated adjusted EBITDA margin y/y contraction, quarterly guideconsolidated adjusted EBITDA margin y/y contraction of approximately 300 to 400 basis pointsJun 2026Jun 2026:we anticipate consolidated year-over-year adjusted EBITDA margin contraction in Q3 of 300 to 400 basis points, similar to the contraction we guided to for Q2.
Call transcript, Jun 2026 · no direct link
New

A verdict describes what became of management’s own words in later analysed calls. “Delayed” is a change of date, “went quiet” a target the calls stopped mentioning. None of it is a judgement on the investment. The methodology sets out how verdicts are recorded.

1 of Coupang, Inc.'s 18 targets was missed. See which ones, and which are quietly gone. The 3 above are the free sample; 15 more targets are in the full ledger.

Free account: 5 full ledgers a month and one Inve Case. US Pro opens 100 a month: first month free, no card.
See the full record

Price

$14.34 +0.49% · +$0.07

Last close Oct 19, 2026 · US · USD

Performance −54.1% 1Y

$15.0$20.0$25.0$30.0Oct 25Dec 25Jan 26Mar 26Apr 26Jun 26Jul 26Aug 26Oct 26Sep 2025 (Q3 FY25) — 4 Nov 2025Dec 2025 (Q4 FY25) — 26 Feb 2026Mar 2026 (Q1 FY26) — 5 May 2026Jun 2026 (Q2 FY26) — 4 Aug 2026

1Y: $31.21 on 17 Oct 2025 → $14.34. High $32.13 (4 Nov 2025), low $13.75 (28 Sept 2026).

Previous close
$14.27
52-week range
$13.75 – $32.13
One year
−54.75%

Overview

Symbol
CPNG
Exchange
US
Currency
USD

Your own record

Start an Inve Case for Coupang, Inc.

Free account. Everything above stays public.

Write why you follow Coupang, Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.

What an account adds